Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful? | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

PostScript

Letter

Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful?

Authors

Arduino Arduini R&D Department, CoreQuest Sagl, Manno, Switzerland PubMed articles Google scholar articles
Victor A Zammit Translational Medicine, Warwick Medical School, University of Warwick, Coventry, UK PubMed articles Google scholar articles
Mario Bonomini Unit of Nephrology and Dialysis, Department of Medicine and Aging Sciences, University of “G. d’Annunzio”, Chieti, Italy PubMed articles Google scholar articles

Correspondence to Dr Arduino Arduini, R&D Department, CoreQuest Sagl, Manno 6928, Switzerland; a.arduini{at}corequest.ch

Citation

Arduini A, Zammit VA, Bonomini M

Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful?

Gut 2020;69:400-401.

Publication history

Received November 27, 2018
Revised December 11, 2018
Accepted December 12, 2018
First published January 11, 2019.

Online issue publication

March 03, 2020

Article Versions

Previous version (7 January 2020).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.